Integral Diagnostics is proud to announce the launch of their latest brand – Chest Scan Australia.
Chest Scan Australia has been developed to ensure easy access to lung cancer screening throughout Australia, bringing the scans our patients need closer. Designed to support the National Lung Cancer Screening Program, Chest Scan combines all of Integral Diagnostics’ expert radiologists, resources, and technology.
With 85 eligible sites across Australia, IDX’s Chest Scan is well-positioned to support patients and referrers with low-dose chest CTs and expert subspeciality chest reporting as part of the National Lung Cancer Screening Program.
Uniting our team of highly trained subspecialty chest radiologists from across Australia, Chest Scan ensures expert interpretation and precise diagnosis. This collaboration enhances accuracy, efficiency, and patient care, ensuring timely and reliable results.
What is the National Lung Cancer Screening Program?
The National Lung Cancer Screening Program (NLCSP) is a major public health advancement, focusing on early detection of lung cancer using low-dose CT scans, with the goal of reducing mortality and supporting high-risk populations.
As of 1st July 2025, Medicare will introduce two new lung screening items as part of the NLCSP. Chest Scan partners support the program and provide fast and easy access to low-dose CT scans for eligible patients at no cost.
Lung cancer is Australia’s leading cause of cancer death, taking over 8,500 lives per year, with most cases diagnosed too late for curative treatment. The National Lung Cancer Screening Program aims to encourage early and regular screening to catch lung cancers in the earlier stages when they are most treatable.
